June 30, 2020
June 30, 2020 —
UC San Diego School of Medicine researchers report that stool microbiomes of NAFLD patients are distinct enough to potentially be used to accurately predict which persons with NAFLD are at greatest risk for having cirrhosis.
July 13, 2020
July 13, 2020 —
By inhibiting the molecule AKT, UC San Diego researchers favor the culture of human spermatogonial stem cells in the lab, a first step toward lab-produced sperm as a treatment for male infertility.
September 29, 2020
September 29, 2020 —
Networking California for Sickle Cell Care Initiative supports expansion of San Diego’s only adult sickle cell disease clinic at UC San Diego Health which offers child-to-adult transition health services to patients like Vanessa Hughes.
July 12, 2021
July 12, 2021 —
UC San Diego researchers discovered that immunotoxins targeting the protein mesothelin prevent liver cells from producing collagen, a precursor to fibrosis and cirrhosis, in mouse models of human disease.
December 1, 2022
December 1, 2022 —
The California Institute for Regenerative Medicine has awarded UC San Diego researchers $4.8 million to advance a gene therapy to treat Friedreich’s ataxia, a rare but devastating neuromuscular disorder.
January 24, 2023
January 24, 2023 —
The gut microbiome plays a critical but poorly understood role in how drugs work or don’t work in the body. It also presents therapeutic possibilities unto itself.
June 26, 2023
June 26, 2023 —
Researchers with UC San Diego School of Medicine identified a potential new drug that improved liver fibrosis in patients with NASH by 27%.
August 23, 2023
August 23, 2023 —
$9 million grant awarded to researchers with UC San Diego School of Medicine supports new study of semaglutide for liver disease.
October 5, 2023
October 5, 2023 —
Daniel John, a bioengineering undergraduate student at UC San Diego, was one of 11 students from across the state awarded the $15,000 Strauss Scholarship for outstanding students developing social change or public service projects.
September 26, 2024
September 26, 2024 —
Patient undergoes 5,000th innovative surgery by a multidisciplinary team at UC San Diego Health to remove blood clots from the lung’s paper-thin arteries.